Honglei Chen

Dr. Honglei Chen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2024 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
SZShaomin Zou
Shaomin Zou
CYChao Yang
Chao Yang
JZJieping Zhang
Jieping Zhang
DZDan Zhong
Dan Zhong
MMManqi Meng
Manqi Meng
LFLekun Fang
Lekun Fang
Background: Colorectal cancer (CRC) is the leading cancer worldwide. Microbial agents have been considered to contribute to the pathogenesis of different disease. But the underlying relevance between CRC and microbiota remain unclear. Methods: We dissected the fecal microbiome structure and genomic and transcriptomic profiles of matched tumor and normal mucosa tissues from 41 CRC patients. Of which, the relationship between CRC-associated bacterial taxa and their significantly correlated somatic mutated gene was investigated by exome sequencing technology. Differentially expressed functional genes in CRC were clustered according to their correlation with differentially abundant species, following by annotation with DAVID. The composition of immune and stromal cell types was identified by XCELL. Results: We identified a set of 22 microbial gut species associated with CRC and estimate the relative abundance of KEGG ontology categories. Next, the interactions between CRC-related gut microbes and clinical phenotypes were evaluated. 4 significantly mutated gene: TP53, APC, KRAS, SMAD4 were pointed out and the associations with cancer related microbes were identified. Among them, Fusobacterium nucleatum positively corelated with different host metabolic pathways. Finally, we revealed that Fusobacterium nucleatum modified the tumor immune environment by TNFSF9 gene expression. Conclusion: Collectively, our multi-omics data could help identify novel biomarkers to inform clinical decision-making in the detection and diagnosis of CRC.

16 December 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
ZYZiqing Yang
Ziqing Yang
DHDandan Huang
Dandan Huang
MMManqi Meng
Manqi Meng
WWWencong Wang
Wencong Wang
JFJunyan Feng
Junyan Feng
SZShaomin Zou
Shaomin Zou
BAF53A, an important subunit of the SWI/SNF epigenetic chromatin regulatory complex, has been implicated as the driver of diverse cancers. However, the role of BAF53A in colorectal cancer (CRC) remains poorly understood. Here, we examined the expression of BAF53A in CRC samples and observed that BAF53A was significantly upregulated in CRC tissues compared with paired adjacent normal tissues. In vitro and in vivo studies suggested that ectopic expression of BAF53A promoted colorectal cancer cell proliferation, colony formation, and tumorigenesis, whereas knockdown of BAF53A hindered these cellular functions. DUSP5 (dual-specificity phosphatase 5), an ERK1/2-specific endogenous phosphatase, was expressed at low levels in CRC. We found a negative correlation between BAF53A and DUSP5 expression in a set of CRC samples. Mechanistic studies revealed that P63 was a potential transcription repressor of DUSP5. BAF53A could interact with P63, decreasing the DUSP5 expression level and subsequently promoting ERK1/2 phosphorylation. Thus, our study provides insights into the applicability of the BAF53A-DUSP5-ERK1/2 axis as a potential therapeutic target in CRC.

16 April 2024 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
LYLiwen Yao
Liwen Yao
HXHuizhen Xiong
Huizhen Xiong
QLQiucheng Li
Qiucheng Li
WWWen Wang
Wen Wang
ZWZhifeng Wu
Zhifeng Wu
HCHonglei Chen
Honglei Chen


23 August 2023 in Pathology - Research and Practice
Verified
Journal Article
Closed access
QHQiaoling Hu
Qiaoling Hu
YGYimin Guo
Yimin Guo
HFHuan Fan
Huan Fan
XWXiaobin Wu
Xiaobin Wu
HCHonglei Chen
Honglei Chen
CZChao Zeng
Chao Zeng

3 January 2026 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Open access
FZFang Zhang
Fang Zhang
YZYoujian Zhou
Youjian Zhou
TXTingting Xia
Tingting Xia
YXYue Xu
Yue Xu
THTaojun He
Taojun He
CWChao Wu
Chao Wu
Helicobacter pylori can cause gastritis, peptic ulcers, and even gastric cancer. In addition to conventional T cells, mucosal-associated invariant T (MAIT) cells may have an important immunologic role in mucosal infectious diseases. However, the phenotypic and effector characteristics of gastric MAIT cells and the relationship between mucosal MAIT cells and H. pylori-related diseases have not been established. We analyzed the phenotypes and cytokines of gastric and peripheral MAIT cells from H. pylori-infected patients by flow cytometry. CXCL12-mediated chemotaxis of MAIT cells was measured by Transwell assay. Relationship between MAIT cells and inflammation of H. pylori-infected gastric diseases was assessed with immunofluorescence staining and histopathological score. The number of gastric MAIT cells was significantly increased but the frequency of peripheral MAIT cells were decreased in patients with H. pylori infections. The gastric MAIT cells were activated with high expression of CD69 and CD38, and produced several pro-inflammatory cytokines. Furthermore, we observed the expression of CXCR4 and CXCL12 were upregulated in H. pylori-infected stomachs. CXCL12 promoted MAIT cells to migrate, which was blocked by a CXCR4 antagonist. Finally, we demonstrated that the number of gastric MAIT cells was positively correlated with severe inflammation in H. pylori-infected stomachs. Gastric MAIT cells were accumulated and activated in H. pylori-infected stomachs, which may be involved in the pathologic inflammation of H. pylori-related gastric diseases.